Institute of Physiology of the Czech Academy of Sciences (IPHYS) is one of the leading research institutions in the Czech Republic. The Institute is engaged in research in the field of normal and pathological physiology, with the main focus on:

• nervous system and brain
• cardiovascular system
• specific aspect of metabolism.

Main goal of the research is to characterize mechanisms of the development of serious human diseases, such as vascular and cerebrovascular accidents, ischemic heart disease, diabetes, hereditary metabolic disorders and neurodegenerative diseases. Centre for Preclinical testing forms a part of the Institute.

• Knowledge of scientists from the Institute of Physiology and their discoveries represent a theoretical basis for the development of new therapies. 
• Institute holds an important role in the education of students and current health care workers.
• Institute of Physiology is consisted of a number of scientific laboratories and service departments. Insitute use the top equipment for the research.
• There are a wide range of world-renowned experts who regularly gain recognition for their scientific work of major domestic and foreign awards.
• Institute´s scientists have worked and still are working on a major social and manager positions (eg. prof. Helena Illnerová - president of The Czech Academy of Sciences 2001 - 2005), including significant positions in the international scientific societies (eg. prof. Bohuslav Ošťádal - president of the International Academy of Cardiovascular Sciences)
• The Institute organise a range of popularization activities for the general and expert public. It has been organizing the series of lectures and seminars (among others Bureš lectures series and the popularisation lectures The human body in health and disease). 
• The Institute has been successful in attracting research funding at both national and international level. It participates also in research projects in the centers of excellence and is also a recipient of EU Structural Funds support. It is the part of a Translational Research Project MediAim that is dedicated to the development of new therapeutic agents and strategies to fight certain serious noncommunicable diseases and selected viral diseases. It´s included three institutions: IKEM, IOCHB and IPHYS.
• The Institute is a co-recipient of the National Recovery Plan (2022 – 2025) in the National Institute for Metabolic and Cardiovascular Disease Research (CarDia) project, whose main goal is to contribute to more effective management of the epidemic of civilization diseases, and in the National Institute for Neurological Research (NPO-NEURO-D) project which focuses on excellent research of disorders of brain development and aging.
• Presentation institute´s brochure (2020), presentation institute´s brochure (2017). 
• Facts and Figures